# Healthpeak Properties Inc. (DOC) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Real Estate / Equity Real Estate Investment Trusts (REITs). Price $20.65, market value $14.6 billion.

## Valuation
- **P/E (trailing): 59.0×** (5-yr avg 57.4×, 3-yr avg 78.4×). Healthpeak Properties Inc. trades at 59.0× trailing earnings, close to its own five-year average of 57.4×. The Real Estate median in the September 2026 study was 25.2×. Forward P/E is 147.5×, higher than trailing, so analysts expect earnings to fall.
- **Price / sales: 20.2×**. Each dollar of revenue is priced at 20.2×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 1.8×**. The shares trade at 1.8× book value; book value is a meaningful part of the valuation.
- **Earnings yield: 1.7%**. The inverse of the P/E: 1.7% of the price is earned each year.

## Profitability
- **Net margin: 11.8%**. 11.8% of each dollar of sales reaches the bottom line.
- **Return on equity: 1.0%**. 1.0% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on assets: 1.2%**. Each dollar of assets produces 1.2% of profit.

## Growth
- **Revenue growth (1 yr): 6.2%** (3-yr 6.9%/yr, 5-yr 6.7%/yr). Revenue grew 6.2% over the last year, against 6.7% a year compounded over five years.
- **EPS growth (1 yr): -72.2%** (3-yr -52.3%/yr, 5-yr -33.5%/yr). Earnings per share fell 72.2%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 1.31**. Debt is 1.31 times equity, a leveraged balance sheet, which is normal for real estate.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 5.91%** ($1.22 per share, trailing). Healthpeak Properties Inc. yields 5.91%, an income-level yield.
- **Dividend growth (5 yr): -12.6%/yr** (1-yr -14.5%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: buy** (19 analysts). 19 analysts cover Healthpeak Properties Inc.; the consensus is buy, with an average price target of $22.92 (+11% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 22.0%** (YTD 33.5%, 3-mo 5.3%). The shares are up 22.0% over twelve months including dividends.
- **From 52-week high: -10.0%** (31.5% above the low). Trading 10% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 41**. An RSI of 41 is neutral.
- **Beta (1 yr): 0.45** (volatility 29%). Beta of 0.45 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=DOC · Page: https://foliofundamentals.com/stocks/doc

Not investment advice.